These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11982606)

  • 1. Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients.
    Ankersmit HJ; Moser B; Zuckermann A; Roth G; Taghavi S; Brunner M; Wolner E; Boltz-Nitulescu G
    Clin Exp Immunol; 2002 Apr; 128(1):175-80. PubMed ID: 11982606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy.
    Ankersmit HJ; Moser B; Roedler S; Teufel I; Zuckermann A; Roth G; Lietz K; Back C; Gerlitz S; Wolner E; Boltz-Nitulescu G
    Clin Exp Immunol; 2002 Jan; 127(1):183-9. PubMed ID: 11882051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation.
    Baan CC; Balk AH; van Riemsdijk IC; Vantrimpont PJ; Maat AP; Niesters HG; Zondervan PE; van Gelder T; Weimar W
    Transplantation; 2003 May; 75(10):1704-10. PubMed ID: 12777860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
    Fulda S; Strauss G; Meyer E; Debatin KM
    Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis.
    Ankersmit HJ; Deicher R; Moser B; Teufel I; Roth G; Gerlitz S; Itescu S; Wolner E; Boltz-Nitulescu G; Kovarik J
    Clin Exp Immunol; 2001 Jul; 125(1):142-8. PubMed ID: 11472437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level.
    Ducoroy P; Micheau O; Perruche S; Dubrez-Daloz L; de Fornel D; Dutartre P; Saas P; Solary E
    Blood; 2003 Jan; 101(1):194-201. PubMed ID: 12393594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by antithymocyte globulin.
    Dubey S; Nityanand S
    Ann Hematol; 2003 Aug; 82(8):496-499. PubMed ID: 12783210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death.
    Tsuruya K; Ninomiya T; Tokumoto M; Hirakawa M; Masutani K; Taniguchi M; Fukuda K; Kanai H; Kishihara K; Hirakata H; Iida M
    Kidney Int; 2003 Jan; 63(1):72-82. PubMed ID: 12472770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance.
    Josien R; Müschen M; Gilbert E; Douillard P; Heslan JM; Soulillou JP; Cuturi MC
    Transplantation; 1998 Oct; 66(7):887-93. PubMed ID: 9798699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperosmolarity triggers CD95 membrane trafficking and sensitizes rat hepatocytes toward CD95L-induced apoptosis.
    Reinehr R; Graf D; Fischer R; Schliess F; Häussinger D
    Hepatology; 2002 Sep; 36(3):602-14. PubMed ID: 12198652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha.
    Gorak-Stolinska P; Truman JP; Kemeny DM; Noble A
    J Leukoc Biol; 2001 Nov; 70(5):756-66. PubMed ID: 11698496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant T-cell activation via CD95 and apoptosis in peripheral T lymphocytes in stable heart transplant recipients.
    Ankersmit HJ; Moser B; Hoffman M; Kocher AA; Schlechta B; Boltz-Nitulescu G; Wolner E
    Transplant Proc; 2001 Aug; 33(5):2860-1. PubMed ID: 11498190
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of the 'silencer of death domain', SODD/BAG-4, modulates both TNFR1- and CD95-dependent cell death pathways.
    Eichholtz-Wirth H; Fritz E; Wolz L
    Cancer Lett; 2003 May; 194(1):81-9. PubMed ID: 12706861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
    Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
    Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.